Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
236
datasets available to search
ShareScore release 0.7.1
Dataset results
236 results for “Immune Thrombocytopenia”
The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia
ClinicalTrials.gov study NCT01667263. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment
ClinicalTrials.gov study NCT01864512. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia
ClinicalTrials.gov study NCT02627417. IPD Sharing: Not stated. Countries: 1. Publications: 6.
to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection
ClinicalTrials.gov study NCT03664518. IPD Sharing: YES. Countries: 1. Publications: 9.
High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
ClinicalTrials.gov study NCT01356511. IPD Sharing: NO. Countries: 1. Publications: 5.
Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia
ClinicalTrials.gov study NCT04737850. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia
ClinicalTrials.gov study NCT03229746. IPD Sharing: NO. Countries: 1. Publications: 5.
Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China
ClinicalTrials.gov study NCT03324087. IPD Sharing: NO. Countries: 1. Publications: 5.
Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia
ClinicalTrials.gov study NCT06497036. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)
ClinicalTrials.gov study NCT02153060. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
ClinicalTrials.gov study NCT06199089. IPD Sharing: YES. Countries: 1. Publications: 1.
A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
ClinicalTrials.gov study NCT05694767. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia
ClinicalTrials.gov study NCT05232149. IPD Sharing: Not stated. Countries: 1. Publications: 1.
All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
ClinicalTrials.gov study NCT01882127. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
ClinicalTrials.gov study NCT02834286. IPD Sharing: YES. Countries: 1. Publications: 4.
The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
ClinicalTrials.gov study NCT04217148. IPD Sharing: YES. Countries: 1. Publications: 1.
Daclizumab to Treat Chronic Immune Thrombocytopenia
ClinicalTrials.gov study NCT00049725. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia
ClinicalTrials.gov study NCT03520049. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia
ClinicalTrials.gov study NCT04014166. IPD Sharing: YES. Countries: 1. Publications: 9.
An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)
ClinicalTrials.gov study NCT01129024. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.